Schroder Investment Management Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.13M | Buy |
225,514
+127,449
| +130% | +$4.59M | 0.01% | 677 |
|
|
2025
Q1 | $3.05M | Sell |
98,065
-98,294
| -50% | -$3.06M | ﹤0.01% | 851 |
|
|
2024
Q4 | $5.01M | Sell |
196,359
-354,483
| -64% | -$9.04M | ﹤0.01% | 769 |
|
|
2024
Q3 | $15.6M | Buy |
550,842
+2,582
| +0.5% | +$73K | 0.02% | 586 |
|
|
2024
Q2 | $14.5M | Sell |
548,260
-4,938
| -0.9% | -$130K | 0.02% | 556 |
|
|
2024
Q1 | $16.8M | Buy |
553,198
+451,942
| +446% | +$13.7M | 0.02% | 536 |
|
|
2023
Q4 | $2.84M | Buy |
101,256
+88,678
| +705% | +$2.49M | ﹤0.01% | 861 |
|
|
2023
Q3 | $341K | Sell |
12,578
-219,241
| -95% | -$5.95M | ﹤0.01% | 1136 |
|
|
2023
Q2 | $7.13M | Buy |
231,819
+2,924
| +1% | +$89.9K | 0.01% | 709 |
|
|
2023
Q1 | $8.25M | Sell |
228,895
-319
| -0.1% | -$11.5K | 0.01% | 669 |
|
|
2022
Q4 | $9.06M | Buy |
229,214
+14,553
| +7% | +$575K | 0.01% | 653 |
|
|
2022
Q3 | $8.63M | Sell |
214,661
-16,293
| -7% | -$655K | 0.01% | 646 |
|
|
2022
Q2 | $9.72M | Buy |
230,954
+36,105
| +19% | +$1.52M | 0.01% | 658 |
|
|
2022
Q1 | $7.6M | Buy |
194,849
+27,517
| +16% | +$1.07M | 0.01% | 731 |
|
|
2021
Q4 | $6.67M | Buy |
167,332
+23,802
| +17% | +$948K | 0.01% | 689 |
|
|
2021
Q3 | $5.19M | Sell |
143,530
-1,398
| -1% | -$50.5K | 0.01% | 781 |
|
|
2021
Q2 | $5.94M | Buy |
144,928
+2,894
| +2% | +$119K | 0.01% | 796 |
|
|
2021
Q1 | $6.2M | Buy |
142,034
+19,752
| +16% | +$862K | 0.01% | 771 |
|
|
2020
Q4 | $6.12M | Sell |
122,282
-1,887
| -2% | -$94.4K | 0.01% | 757 |
|
|
2020
Q3 | $5.27M | Buy |
124,169
+26,563
| +27% | +$1.13M | 0.01% | 715 |
|
|
2020
Q2 | $4.74M | Buy |
+97,606
| New | +$4.74M | 0.01% | 684 |
|